CGH
EHC icon

Crossmark Global Holdings’s Encompass Health EHC Stock Holding History

Crossmark Global Holdings’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Buy
9,284
+117
+1% +$12.1K 0.01% 644
2026
Q1 		$887K Sell
9,167
-80
-0.9% -$8.2K 0.01% 643
2025
Q4 		$981K Buy
9,247
+874
+10% +$101K 0.01% 611
2025
Q3 		$1.06M Sell
8,373
-760
-8% -$90.5K 0.02% 606
2025
Q2 		$1.12M Buy
9,133
+1,252
+16% +$143K 0.02% 573
2025
Q1 		$798K Sell
7,881
-34
-0.4% -$3.32K 0.01% 679
2024
Q4 		$731K Sell
7,915
-37
-0.5% -$3.63K 0.01% 681
2024
Q3 		$769K Buy
7,952
+612
+8% +$55K 0.01% 695
2024
Q2 		$630K Sell
7,340
-586
-7% -$49.2K 0.01% 740
2024
Q1 		$655K Sell
7,926
-153
-2% -$11.2K 0.01% 755
2023
Q4 		$539K Sell
8,079
-683
-8% -$44.2K 0.01% 812
2023
Q3 		$577K Sell
8,762
-641
-7% -$44.1K 0.01% 755
2023
Q2 		$621K Sell
9,403
-82
-0.9% -$5.14K 0.01% 747
2023
Q1 		$513K Sell
9,485
-56
-0.6% -$3.26K 0.01% 814
2022
Q4 		$571K Buy
9,541
+91
+1% +$4.95K 0.01% 739
2022
Q3 		$427K Sell
9,450
-139,649
-94% -$6.99M 0.01% 836
2022
Q2 		$6.65M Buy
149,099
+588
+0.4% +$30.2K 0.17% 151
2022
Q1 		$8.4M Buy
148,511
+136,117
+1,098% +$7.11M 0.19% 141
2021
Q4 		$643K Buy
12,394
+99
+0.8% +$5.11K 0.01% 793
2021
Q3 		$734K Sell
12,295
-25
-0.2% -$1.57K 0.02% 732
2021
Q2 		$765K Sell
12,320
-159
-1% -$10.6K 0.02% 703
2021
Q1 		$813K Sell
12,479
-150,039
-92% -$9.79M 0.02% 672
2020
Q4 		$10.7M Sell
162,518
-11,160
-6% -$657K 0.27% 88
2020
Q3 		$8.98M Sell
173,678
-4,610
-3% -$237K 0.25% 101
2020
Q2 		$8.78M Sell
178,288
-6,313
-3% -$341K 0.26% 97
2020
Q1 		$9.4M Sell
184,601
-20,913
-10% -$1.21M 0.34% 81
2019
Q4 		$11.3M Buy
205,514
+1,166
+0.6% +$63.3K 0.31% 86
2019
Q3 		$10.3M Sell
204,348
-3,098
-1% -$156K 0.3% 85
2019
Q2 		$10.5M Buy
207,446
+148
+0.1% +$7.18K 0.29% 81
2019
Q1 		$9.63M Sell
207,298
-2,272
-1% -$115K 0.27% 90
2018
Q4 		$10.3M Sell
209,570
-1,739
-0.8% -$98.9K 0.32% 72
2018
Q3 		$13.1M Buy
211,309
+7,395
+4% +$450K 0.33% 62
2018
Q2 		$11M Buy
203,914
+10,696
+6% +$535K 0.29% 76
2018
Q1 		$8.79M Buy
193,218
+15,557
+9% +$667K 0.23% 113
2017
Q4 		$6.98M Buy
177,661
+2,423
+1% +$92.2K 0.17% 150
2017
Q3 		$6.46M Buy
+175,238
New +$6.24M 0.17% 150
2016
Q3 		$6.46M Buy
+175,238
New +$5.68M 0.17% 150

Other funds holding EHC

RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
SCM
Seascape Capital Management Portsmouth, New Hampshire $417M AUM 41.98% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Crossmark Global Holdings's EHC Position: Q2 2026 in Review

Crossmark Global Holdings increased its Encompass Health (EHC) stake by 1.3% in Q2 2026, buying an estimated $12.1K and bringing the position to 9,284 shares worth $938K. The position accounts for 0.01% of the portfolio, ranked #644.

Crossmark Global Holdings first reported a position in EHC in Q3 2016 and has held it in 37 quarters since. The position peaked at $13.1M in Q3 2018. 79 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Crossmark Global Holdings held 9,284 shares of Encompass Health worth $938K as of Q2 2026.
  • Crossmark Global Holdings bought 117 Encompass Health shares in Q2 2026, an estimated $12.1K.
  • Encompass Health made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #644 holding.
  • Crossmark Global Holdings first reported a position in Encompass Health in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Encompass Health position peaked at $13.1M in Q3 2018.
  • 79 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.